4SC | resminostat | Oncology |
7 HILLS | alintegimod | Oncology |
AADI BIOSCIENCE | FYARRO | Oncology |
ABBOTT LABORATORIES | enavatuzumab | Oncology |
ABBVIE | azintuxizumab | Oncology |
ABBVIE | azintuxizumab vedotin | Oncology |
ABBVIE | budigalimab | Oncology |
ABBVIE | cedirogant | Oncology |
ABBVIE | depatuxizumab | Oncology |
ABBVIE | depatuxizumab mafodotin | Oncology |
ABBVIE | eftozanermin alfa | Oncology |
ABBVIE | elotuzumab | Oncology |
ABBVIE | giloralimab | Oncology |
ABBVIE | ilorasertib | Oncology |
ABBVIE | linifanib | Oncology |
ABBVIE | livmoniplimab | Oncology |
ABBVIE | mirzotamab | Oncology |
ABBVIE | mirzotamab clezutoclax | Oncology |
ABBVIE | revdofilimab | Oncology |
ABBVIE | rizankizumab | Oncology |
ABBVIE | rolinsatamab | Oncology |
ABBVIE | rolinsatamab talirine | Oncology |
ABBVIE | rovalpituzumab | Oncology |
ABBVIE | rovalpituzumab tesirine | Oncology |
ABBVIE | samrotamab | Oncology |
ABBVIE | samrotamab vedotin | Oncology |
ABBVIE | serclutamab | Oncology |
ABBVIE | serclutamab talirine | Oncology |
ABBVIE | tamrintamab | Oncology |
ABBVIE | tamrintamab pamozirineab | Oncology |
ABBVIE | telisotuzumab | Oncology |
ABBVIE | telisotuzumab vedotin | Oncology |
ABBVIE | TEPKINLY | Oncology |
ABBVIE | veliparib | Oncology |
ABBVIE | venetoclax | Oncology |
ABION | vabametkib | Oncology |
ACCORD HEALTHCARE | CAMCEVI | Oncology |
ACERTA PHARMA | acalabrutinib | Oncology |
ACERTA PHARMA | CALQUENCE * | Oncology |
ACETYLON PHARMACEUTICALS | ricolinostat | Oncology |
ACTINIUM | actinium (225ac) lintuzumab satetraxetan | Oncology |
ACTINIUM | iodine (131i) apamistamab | Oncology |
ACTUATE THERAPEUTICS | elraglusib | Oncology |
ADAGENE | firastotug | Oncology |
ADAGENE | muzastotug | Oncology |
ADAPTIMMUNE | afamitresgene autoleucel | Oncology |
ADAPTIMMUNE | letetresgene autoleucel | Oncology |
ADAPTIMMUNE | olitresgene autoleucel | Oncology |
ADC THERAPEUTICS | camidanlumab | Oncology |
ADC THERAPEUTICS | camidanlumab tesirine | Oncology |
ADC THERAPEUTICS | loncastuximab | Oncology |
ADC THERAPEUTICS | loncastuximab tesirine | Oncology |
ADC THERAPEUTICS | mipasetamab | Oncology |
ADC THERAPEUTICS | mipasetamab uzoptirine | Oncology |
ADC THERAPEUTICS | ZYNLONTA * | Oncology |
ADVANCED ACCELERATOR APPLICATIONS | LOCAMETZ | Oncology |
ADVAXIS | axalimogene filolisbac | Oncology |
ADVAXIS | capolimogene apralisbac | Oncology |
AFFIBODY | tezatabep matraxetan | Oncology |
AFFIMED | acimtamig | Oncology |
AGENUS | botensilimab | Oncology |
AGIOS PHARMACEUTICALS | enasidenib | Oncology |
AGIOS PHARMACEUTICALS | ivosidenib | Oncology |
AGIOS PHARMACEUTICALS | vorasidenib | Oncology |
AGIOS PHARMACEUTICALS | vorasidenib citrate | Oncology |
AILERON THERAPEUTICS | sulanemadlin | Oncology |
ALEXION PHARMACEUTICALS | cerdulatinib | Oncology |
ALKERMES | nemvaleukin alfa | Oncology |
ALLOGENE | alemtuzumab beta | Oncology |
AMGEN | acapatamab | Oncology |
AMGEN | alsevalimab | Oncology |
AMGEN | bemarituzumab | Oncology |
AMGEN | bevacizumab beta | Oncology |
AMGEN | BLINCYTO | Oncology |
AMGEN | BLINCYTO ((ビーリンサイト) * | Oncology |
AMGEN | cabiralizumab | Oncology |
AMGEN | eluvixtamab | Oncology |
AMGEN | emerfetamab | Oncology |
AMGEN | emirodatamab | Oncology |
AMGEN | etevritamab | Oncology |
AMGEN | gresonitamab | Oncology |
AMGEN | inezetamab | Oncology |
AMGEN | KANJINTI * | Oncology |
AMGEN | KYPROLIS * | Oncology |
AMGEN | latikafusp | Oncology |
AMGEN | LUMAKRAS | Oncology |
AMGEN | LUMYKRAS | Oncology |
AMGEN | murizatoclax | Oncology |
AMGEN | MVASI * | Oncology |
AMGEN | oprozomib | Oncology |
AMGEN | pacanalotamab | Oncology |
AMGEN | pavurutamab | Oncology |
AMGEN | sotorasib | Oncology |
AMGEN | sovilnesib | Oncology |
AMGEN | tapotoclax | Oncology |
AMGEN | tarlatamab | Oncology |
AMGEN | trebananib | Oncology |
AMGEN | VECTIBIX | Oncology |
AMGEN | vepsitamab | Oncology |
AMGEN | xaluritamig | Oncology |
AMGEN | XGEVA | Oncology |
AMGEN | zeluvalimab | Oncology |
AMNEAL PHARMACEUTICALS | ALYMSYS * | Oncology |
AMPHIVENA THERAPEUTICS | vixtimotamab | Oncology |
ANHEART THERAPEUTICS | taletrectinib | Oncology |
ANHEART THERAPEUTICS | taletrectinib adipate | Oncology |
APEIRON BIOLOGICS | lorukafusp alfa | Oncology |
APOTEX | docetaxel | Oncology |
APREA THERAPEUTICS | eprenetapopt | Oncology |
ARCELIX | anitocabtagene autoleucel | Oncology |
ARCUS BIOSCIENCES | domvanalimab | Oncology |
ARCUS BIOSCIENCES | etrumadenant | Oncology |
ARCUS BIOSCIENCES | quemliclustat | Oncology |
ARCUS BIOSCIENCES | ralzapastotug | Oncology |
ARCUS BIOSCIENCES | zimberelimab | Oncology |
ARIAD PHARMACEUTICALS | ALUNBRIG | Oncology |
ARIAD PHARMACEUTICALS | ICLUSIG | Oncology |
ARIAD PHARMACEUTICALS | ponatinib | Oncology |
ARIAD PHARMACEUTICALS | ponatinib hydrochloride | Oncology |
ARIVIVE | batiraxcept | Oncology |
ARVINAS | bavdegalutamide | Oncology |
ASCENTAGE PHARMA | alrizomadlin | Oncology |
ASCENTAGE PHARMA | lisaftoclax | Oncology |
ASCENTAGE PHARMA | olverembatinib | Oncology |
ASCENTAGE PHARMA | pelcitoclax | Oncology |
ASTELLAS | gilteritinib | Oncology |
ASTELLAS | torulimogene lonferencel | Oncology |
ASTELLAS | XTANDI | Oncology |
ASTELLAS | zolbetuximab | Oncology |
ASTELLAS ONCOLOGY | XOSPATA * | Oncology |
ASTEX PHARMACEUTICALS | cedazuridine | Oncology |
ASTEX PHARMACEUTICALS | guadecitabine | Oncology |
ASTEX PHARMACEUTICALS | INQOVI * | Oncology |
ASTRAZENECA | acalabrutinib | Oncology |
ASTRAZENECA | adavosertib | Oncology |
ASTRAZENECA | bicalutamide | Oncology |
ASTRAZENECA | camizestrant | Oncology |
ASTRAZENECA | capivasertib | Oncology |
ASTRAZENECA | CAPRELSA | Oncology |
ASTRAZENECA | CASODEX | Oncology |
ASTRAZENECA | CASODEX OD (カソデックスOD) | Oncology |
ASTRAZENECA | ceralasertib | Oncology |
ASTRAZENECA | danvatirsen | Oncology |
ASTRAZENECA | defosbarasertib | Oncology |
ASTRAZENECA | ENHERTU | Oncology |
ASTRAZENECA | falbikitug | Oncology |
ASTRAZENECA | FASLODEX * | Oncology |
ASTRAZENECA | IMJUDO | Oncology |
ASTRAZENECA | IRESSA * | Oncology |
ASTRAZENECA | KOSELUGO * | Oncology |
ASTRAZENECA | LUMOXITI | Oncology |
ASTRAZENECA | puxitatug | Oncology |
ASTRAZENECA | puxitatug samrotecan | Oncology |
ASTRAZENECA | rilvegostomig | Oncology |
ASTRAZENECA | sabestomig | Oncology |
ASTRAZENECA | saruparib | Oncology |
ASTRAZENECA | savolitinib | Oncology |
ASTRAZENECA | selumetinib | Oncology |
ASTRAZENECA | selumetinib sulfate | Oncology |
ASTRAZENECA | TAGRISSO (Тагриссо) * | Oncology |
ASTRAZENECA | telratolimod | Oncology |
ASTRAZENECA | ZOLADEX | Oncology |
ATEA PHARMACEUTICALS | bemnifosbuvir | Oncology |
ATEA PHARMACEUTICALS | bemnifosbuvir sulfate | Oncology |
ATHENEX | encequidar | Oncology |
ATHENEX | tirbanibulin | Oncology |
ATRIX LABORATORIES | ELIGARD * | Oncology |
AURINIA PHARMACEUTICALS | terameprocol | Oncology |
AUTOLUS THERAPEUTICS | dalucabtagene autoleucel | Oncology |
AUTOLUS THERAPEUTICS | obecabtagene autoleucel | Oncology |
AVELAS BIOSCIENCES | pegloprastide | Oncology |
BASILEA PHARMACEUTICA | avanbulin | Oncology |
BASILEA PHARMACEUTICA | lisavanbulin | Oncology |
BAYER | ALIQOPA * | Oncology |
BAYER | aprutumab | Oncology |
BAYER | aprutumab ixadotin | Oncology |
BAYER | copanlisib | Oncology |
BAYER | darolutamide | Oncology |
BAYER | NEXAVAR * | Oncology |
BAYER | NUBEQA (ニュベクオ) | Oncology |
BAYER | radretumab | Oncology |
BAYER | refametinib | Oncology |
BAYER | roniciclib | Oncology |
BAYER | sorafenib | Oncology |
BAYER | VIADUR | Oncology |
BAYER | VITRAKVI * | Oncology |
BAYER | XOFIGO | Oncology |
BAYER | XOFIGO (RADIUM RA 223 DICHLORIDE) | Oncology |
BEIGENE | BRUKINSA * | Oncology |
BEIGENE | garivulimab | Oncology |
BEIGENE | lifirafenib | Oncology |
BEIGENE | ociperlimab | Oncology |
BEIGENE | pamiparib | Oncology |
BEIGENE | sonrotoclax | Oncology |
BEIGENE | surzebiclimab | Oncology |
BEIGENE | tislelizumab | Oncology |
BEIGENE | verzistobart | Oncology |
BEIGENE | zanubrutinib | Oncology |
BELLICUM PHARMACEUTICALS | rimiducid | Oncology |
BERGEN BIO | bemcentinib | Oncology |
BERGEN BIO | tilvestamab | Oncology |
BETA PHARMA | eciruciclib | Oncology |
BETA PHARMA | rezivertinib | Oncology |
BETACAT | tegavivint | Oncology |
BEYONDBIO | avotaciclib | Oncology |
BIO-PATH HOLDINGS | prexigebersen | Oncology |
BIOCANCELL THERAPEUTICS | inodiftagene vixteplasmid | Oncology |
BIOGEN | RITUXAN | Oncology |
BIOINVENT INTERNATIONAL | bersanlimab | Oncology |
BIOLINE RX | motixafortide | Oncology |
BIOMED VALLEY | ulixertinib | Oncology |
BIONOVUS LIFE SCIENCES | fosciclopirox | Oncology |
BIONUMERIK PHARMACEUTICALS | TAVOCEPT | Oncology |
BIOSIGHT | aspacytarabine | Oncology |
BIPAR | iniparib | Oncology |
BLACK DIAMOND | tuxobertinib | Oncology |
BLAZE BIOSCIENCE | tozuleristide | Oncology |
BLUE EARTH DIAGNOSTICS | flotufolastat (18f) * | Oncology |
BLUE EARTH DIAGNOSTICS | flotufolastat f 18 gallium | Oncology |
BLUEPRINT MEDICINES | avapritinib | Oncology |
BLUEPRINT MEDICINES | AYVAKIT | Oncology |
BLUEPRINT MEDICINES | fisogatinib | Oncology |
BLUEPRINT MEDICINES | pralsetinib | Oncology |
BOEHRINGER INGELHEIM | brigimadlin | Oncology |
BOEHRINGER INGELHEIM | GILOTRIF | Oncology |
BOEHRINGER INGELHEIM | GIOTRIF | Oncology |
BOSTON PHARMACEUTICALS | zeteletinib | Oncology |
BOSTON PHARMACEUTICALS | zeteletinib adipate | Oncology |
BRISTOL MYERS SQUIBB | alvespimycin | Oncology |
BRISTOL MYERS SQUIBB | alvespimycin hydrochloride | Oncology |
BRISTOL MYERS SQUIBB | amrubicin hydrochloride | Oncology |
BRISTOL MYERS SQUIBB | BREYANZI * | Oncology |
BRISTOL MYERS SQUIBB | ISTODAX * | Oncology |
BRISTOL MYERS SQUIBB | onatasertib | Oncology |
BRISTOL MYERS SQUIBB | onatasertib | Oncology |
BRISTOL MYERS SQUIBB | OPDUALAG | Oncology |
BRISTOL MYERS SQUIBB | orvacabtagene autoleucel | Oncology |
BRISTOL MYERS SQUIBB | pomalidomide | Oncology |
BRISTOL MYERS SQUIBB | tanespimycin | Oncology |
BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
BRISTOL MYERS SQUIBB | vadacabtagene leraleucel | Oncology |
BRISTOL MYERS SQUIBB | VIDAZA | Oncology |
C4 THERAPEUTICS | cemsidomide | Oncology |
CALITHERA | telaglenastat | Oncology |
CANTEX PHARMACEUTICALS | dociparstat | Oncology |
CARNA | monzosertib | Oncology |
CARNA | sofnobrutinib | Oncology |
CASI PHARMACEUTICALS | PANZEM | Oncology |
CASI PHARMACEUTICALS | PROMUNE | Oncology |
CELLID | vibapapogene autoleucel | Oncology |
CELLTRION HEALTHCARE | BLITZIMA | Oncology |
CELLTRION HEALTHCARE | HERZUMA | Oncology |
CELLTRION HEALTHCARE | RITEMVIA | Oncology |
CELLTRION HEALTHCARE | TRUXIMA | Oncology |
CELLTRION HEALTHCARE | TUXELLA | Oncology |
CELLTRION HEALTHCARE | VEGZELMA | Oncology |
CEPTARIS THERAPEUTICS | VALCHLOR * | Oncology |
CERULEAN | davamotecan pegadexamer | Oncology |
CHECKPOINT THERAPEUTICS | cosibelimab | Oncology |
CHECKPOINT THERAPEUTICS | olafertinib | Oncology |
CHINOOK THERAPEUTICS | damistimagene matitucel | Oncology |
CHINOOK THERAPEUTICS | enistimagene setitucel | Oncology |
CHONG KUN DANG | alteminostat | Oncology |
CHONG KUN DANG | valecobulin | Oncology |
CHUGAI PHARMA | ALECENSA * | Oncology |
CHUGAI PHARMA | ROZLYTREK (ロズリートレク) | Oncology |
CLOVIS ONCOLOGY | rociletinib | Oncology |
CLOVIS ONCOLOGY | RUBRACA * | Oncology |
COHERUS BIOSCIENCES | LOQTORZI | Oncology |
CONSTELLATION PHARMACEUTICALS | lirametostat | Oncology |
CONSTELLATION PHARMACEUTICALS | pelabresib | Oncology |
CONSTELLATION PHARMACEUTICALS | tulmimetostat | Oncology |
CRISPR | evoncabtagene pazurgedleucel | Oncology |
CRISPR THERAPEUTICS | motacabtagene lurevgedleucel | Oncology |
CRISPR THERAPEUTICS | volamcabtagene durzigedleucel | Oncology |
CULLINAN ONCOLOGY | zipalertinib | Oncology |
CURIS | emavusertib | Oncology |
CURIS | emavusertib hydrochloride | Oncology |
CURIS | emavusertib maleate | Oncology |
CURIS | emavusertib mesylate | Oncology |
CURIS | emavusertib phosphate | Oncology |
CURIS | emavusertib tosylate | Oncology |
CURIUM PET FRANCE | PYLCLARI | Oncology |
CUROCELL | anbalcabtagene autoleucel | Oncology |
CYTOMX THERAPEUTICS | pacmilimab | Oncology |
CYTOMX THERAPEUTICS | praluzatamab | Oncology |
CYTOMX THERAPEUTICS | praluzatamab ravtansine | Oncology |
DAIICHI SANKYO | datopotamab | Oncology |
DAIICHI SANKYO | datopotamab deruxtecan | Oncology |
DAIICHI SANKYO | ENHERTU (エンハーツ) | Oncology |
DAIICHI SANKYO | EZHARMIA | Oncology |
DAIICHI SANKYO | patritumab | Oncology |
DAIICHI SANKYO | pexidartinib | Oncology |
DAIICHI SANKYO | safusidenib | Oncology |
DAIICHI SANKYO | tivantinib | Oncology |
DAIICHI SANKYO | TURALIO * | Oncology |
DAIICHI SANKYO | VANFLYTA | Oncology |
DAIICHI SANKYO | VANFLYTA (ヴァンフリタ) * | Oncology |
DECIPHERA PHARMACEUTICALS | QINLOCK * | Oncology |
DECIPHERA PHARMACEUTICALS | QINLOCK * | Oncology |
DECIPHERA PHARMACEUTICALS | vimseltinib | Oncology |
DEKK-TEC | mipicoledine | Oncology |
DENDREON | lapuleucel-t | Oncology |
DENDREON | PROVENGE | Oncology |
DENDREON | sipuleucel-t | Oncology |
DNATRIX | tezemlimogene daxadenorepvec | Oncology |
DNATRIX, INC. | tasadenoturev | Oncology |
DOT-THERAPEUTICS-1 | tovorafenib | Oncology |
DR. REDDY'S LAB | ESAMUZE | Oncology |
DR. REDDY'S LAB | HERVYCTA | Oncology |
EAGLE PHARMACEUTICALS | BELRAPZO | Oncology |
EAGLE PHARMACEUTICALS | BENDEKA * | Oncology |
EFFECTOR | tomivosertib | Oncology |
EFFECTOR | zotatifin | Oncology |
EISAI | DACOGEN | Oncology |
EISAI | HALAVEN | Oncology |
EISAI | KISPLYX | Oncology |
EISAI | LENVIMA | Oncology |
EMD SERONO | evobrutinib | Oncology |
ENZYCHEM | mosedipimod | Oncology |
EPIZYME | pinometostat | Oncology |
EPIZYME | tazemetostat | Oncology |
EPIZYME | TAZVERIK * | Oncology |
EQRX | aumolertinib | Oncology |
EQRX | aumolertinib mesylate | Oncology |
ERIMOS PHARMACEUTICALS | terameprocol | Oncology |
EUSA PHARMA | QARZIBA | Oncology |
EXELIXIS | cabozantinib | Oncology |
EXELIXIS | zanzalintinib | Oncology |
EXELIXIS | zanzalintinib fumarate | Oncology |
FENNEC PHARMACEUTICALS | PEDMARQSI | Oncology |
FORMA | pocenbrodib | Oncology |
FORMA THERAPEUTICS | REZLIDHIA | Oncology |
FORSEE PHARMACEUTICALS | CAMCEVI KIT | Oncology |
GALERA THERAPEUTICS | rucosopasem manganese | Oncology |
GAMAMABS | murlentamab | Oncology |
GEISTLICH PHARMA | misetionamide | Oncology |
GENEMEDICINE | opilrelagene atradenorepvec | Oncology |
GENENTECH | ALECENSA * | Oncology |
GENENTECH | atezolizumab | Oncology |
GENENTECH | autogene cevumeran | Oncology |
GENENTECH | autogene cevumeran | Oncology |
GENENTECH | AVASTIN * | Oncology |
GENENTECH | cevostamab | Oncology |
GENENTECH | cobimetinib | Oncology |
GENENTECH | dulanermin | Oncology |
GENENTECH | duligotuzumab | Oncology |
GENENTECH | GAZYVA * | Oncology |
GENENTECH | HERCEPTIN HYLECTA * | Oncology |
GENENTECH | ipatasertib | Oncology |
GENENTECH | KADCYLA | Oncology |
GENENTECH | KADCYLA (カドサイラ) | Oncology |
GENENTECH | mosunetuzumab | Oncology |
GENENTECH | PERJETA | Oncology |
GENENTECH | PERJETA (パージェタ) * | Oncology |
GENENTECH | pinatuzumab vedotin | Oncology |
GENENTECH | polatuzumab vedotin | Oncology |
GENENTECH | POLIVY * | Oncology |
GENENTECH | RITUXAN | Oncology |
GENENTECH | ROZLYTREK | Oncology |
GENENTECH | runimotamab | Oncology |
GENENTECH | TARCEVA * | Oncology |
GENENTECH | taselisib | Oncology |
GENENTECH | TECENTRIQ * | Oncology |
GENENTECH | tiragolumab | Oncology |
GENEXINE | efineptakin alfa | Oncology |
GENEXINE | tirvalimogene teraplasmid | Oncology |
GENMAB | ARZERRA (アーゼラ) | Oncology |
GENMAB | EPKINLY | Oncology |
GENMAB | TIVDAK | Oncology |
GENOMIC HEALTH | GENOMIC PROSTATE SCORE (GPS) | Oncology |
GENORBIO | coprelotamab | Oncology |
GENORBIO | geptanolimab | Oncology |
GENTA | GENASENSE | Oncology |
GERON | paclitaxel trevatide | Oncology |
GILEAD | acalisib | Oncology |
GILEAD | alobresib | Oncology |
GILEAD | andecaliximab | Oncology |
GILEAD | dalutrafusp alfa | Oncology |
GILEAD | entospletinib | Oncology |
GILEAD | epacmarstobart | Oncology |
GILEAD | evixapodlin | Oncology |
GILEAD | idelalisib | Oncology |
GILEAD | magrolimab | Oncology |
GILEAD | simtuzumab | Oncology |
GILEAD | tilpisertib | Oncology |
GILEAD | tirabrutinib | Oncology |
GILEAD | tirabrutinib hydrochloride | Oncology |
GILEAD | vesatolimod | Oncology |
GLENMARK PHARMACEUTICALS | telazorlimab | Oncology |
GLYCOTOPE | gatipotuzumab | Oncology |
GLYCOTOPE | timigutuzumab | Oncology |
GLYCOTOPE | tomuzotuximab | Oncology |
GSK | ARZERRA | Oncology |
GSK | ARZERRA (アーゼラ) | Oncology |
GSK | astuprotimut-r | Oncology |
GSK | belantamab | Oncology |
GSK | belantamab mafodotin | Oncology |
GSK | belizatinib | Oncology |
GSK | besvatresgene autoleucel | Oncology |
GSK | BEXXAR * | Oncology |
GSK | BLENREP * | Oncology |
GSK | CYTEFURAN | Oncology |
GSK | encelimab | Oncology |
GSK | feladilimab | Oncology |
GSK | JEMPERLI * | Oncology |
GSK | MEKINIST * | Oncology |
GSK | molibresib | Oncology |
GSK | nelistotug | Oncology |
GSK | omipalisib | Oncology |
GSK | pemrametostat | Oncology |
GSK | REZONIC | Oncology |
GSK | suvutresgene autoleucel | Oncology |
GSK | TAFINLAR * | Oncology |
GSK | uprosertib | Oncology |
GSK | VOTRIENT * | Oncology |
GSK | zastumotide | Oncology |
HALOZYME THERAPEUTICS | pegvorhyaluronidase alfa | Oncology |
HANMI PHARMACEUTICALS | belvarafenib | Oncology |
HANMI PHARMACEUTICALS | olmutinib | Oncology |
HANMI PHARMACEUTICALS | poseltinib | Oncology |
HELSINN HEALTHCARE | AMIXEA | Oncology |
HELSINN HEALTHCARE | RESSURO | Oncology |
HOOKIPA PHARMA | esepapogene zalarnarepvec | Oncology |
HOOKIPA PHARMA | ninsipapogene sibarnarepvec | Oncology |
HUYA | HIYASTA | Oncology |
I-MAB | lemzoparlimab | Oncology |
I-MAB | uliledlimab | Oncology |
IDEAYA BIOSCIENCES | darovasertib | Oncology |
IDERA PHARMACEUTICALS | tilsotolimod | Oncology |
IGNYTA | entrectinib | Oncology |
IMMUNEONCO | timdarpacept | Oncology |
IMMUNOCORE | brenetafusp | Oncology |
IMMUNOCORE | KIMMTRAK * | Oncology |
IMMUNOGEN | cantuzumab ravtansine | Oncology |
IMMUNOGEN | laprituximab | Oncology |
IMMUNOGEN | laprituximab emtansine | Oncology |
IMMUNOGEN | lorvotuzumab mertansine | Oncology |
IMMUNOGEN | mirvetuximab soravtansine | Oncology |
IMMUNOGEN | naratuximab emtansine | Oncology |
IMMUNOMIC THERAPEUTICS | umitrelimorgene autodencel | Oncology |
INCYTE | PEMAZYRE * | Oncology |
INCYTE | pemigatinib | Oncology |
INHIBRX | enristomig | Oncology |
INMED | ifebemtinib | Oncology |
INNOCRIN PHARMACEUTICALS | seviteronel | Oncology |
INOVIO | bizalimogene ralaplasmid | Oncology |
INOVIO | mavilimogene ralaplasmid | Oncology |
INSPIRNA | abequolixron | Oncology |
INSPIRNA | abequolixron zinc | Oncology |
INSPYR THERAPEUTICS | mipsagargin | Oncology |
INSTIL BIO | cenzileucel | Oncology |
INTREXON | veledimex | Oncology |
INTROGEN THERAPEUTICS | ADVEXIN * | Oncology |
IOVANCE BIOTHERAPEUTICS | lifileucel | Oncology |
IPR PHARMS | CAPRELSA | Oncology |
IPSEN BIOPHARM | CABOMETYX (カボメティクス) * | Oncology |
IPSEN BIOPHARM LTD | satoreotide tetraxetan | Oncology |
IPSEN BIOPHARM LTD | zalsenertant tetraxetan | Oncology |
IPSEN/TERCICA | SOMATULINE DEPOT | Oncology |
ISOFOL | arfolitixorin | Oncology |
ISTARI ONCOLOGY | lerapolturev | Oncology |
ISTARI ONCOLOGY | lerapolturev | Oncology |
ISU ABXIS | barecetamab | Oncology |
J&J INNOVATIVE MEDICINE | amivantamab | Oncology |
J&J INNOVATIVE MEDICINE | apalutamide | Oncology |
J&J INNOVATIVE MEDICINE | cetrelimab | Oncology |
J&J INNOVATIVE MEDICINE | ciduvectamig | Oncology |
J&J INNOVATIVE MEDICINE | ciltacabtagene autoleucel | Oncology |
J&J INNOVATIVE MEDICINE | daratumumab | Oncology |
J&J INNOVATIVE MEDICINE | duvortuxizumab | Oncology |
J&J INNOVATIVE MEDICINE | erdafitinib | Oncology |
J&J INNOVATIVE MEDICINE | lazertinib | Oncology |
J&J INNOVATIVE MEDICINE | lorpucitinib | Oncology |
J&J INNOVATIVE MEDICINE | mitazalimab | Oncology |
J&J INNOVATIVE MEDICINE | onametostat | Oncology |
J&J INNOVATIVE MEDICINE | onvatilimab | Oncology |
J&J INNOVATIVE MEDICINE | opolimogene capmilisbac | Oncology |
J&J INNOVATIVE MEDICINE | pemlimogene merolisbac | Oncology |
J&J INNOVATIVE MEDICINE | seltorexant | Oncology |
J&J INNOVATIVE MEDICINE | talacotuzumab | Oncology |
J&J INNOVATIVE MEDICINE | talquetamab | Oncology |
J&J INNOVATIVE MEDICINE | teclistamab | Oncology |
J&J INNOVATIVE MEDICINE | voxalatamab | Oncology |
J-PHARMA | nanvuranlat | Oncology |
JAZZ PHARMACEUTICALS | ENRYLAZE | Oncology |
JAZZ PHARMACEUTICALS | pegcrisantaspase | Oncology |
JAZZ PHARMACEUTICALS | RYLAZE * | Oncology |
JAZZ PHARMACEUTICALS | VYXEOS * | Oncology |
JAZZ PHARMACEUTICALS | ZEPZELCA * | Oncology |
JEIL PHARMACEUTICAL | nesuparib | Oncology |
JOHNSON & JOHNSON | intetumumab | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | AKEEGA | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | BALVERSA * | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | carlumab | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | CARVYKTI | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | DARZALEX | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | DARZALEX FASPRO | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | DARZQURO | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | ERLEADA | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | quisinostat | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | RYBREVANT * | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | serdemetan | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | siltuximab | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | SYLVANT | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | talmapimod | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | TALVEY | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | TECVALYI * | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | TECVAYLI | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | YONDELIS * | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | ZYTIGA | Oncology |
JOHNSON & JOHNSON INNOVATIVE MEDICINE | ZYTIGA (Зитига) * | Oncology |
JOUNCE THERAPEUTICS | pimivalimab | Oncology |
JOUNCE THERAPEUTICS | polzastobart | Oncology |
JOUNCE THERAPEUTICS | vopratelimab | Oncology |
JW PHARMACEUTICAL | relmacabtagene autoleucel | Oncology |
JW THERAPEUTICS | lisocabtagene maraleucel | Oncology |
KARTOS | navtemadlin | Oncology |
KARYOPHARM | NEXPOVIO * | Oncology |
KARYOPHARM | selinexor | Oncology |
KARYOPHARM | XPOVIO * | Oncology |
KARYOPHARM THERAPEUTICS | padnarsertib | Oncology |
KEROS | elritercept | Oncology |
KINNATE BIOPHARMA | exarafenib | Oncology |
KURA ONCOLOGY | edaxeterkib | Oncology |
KURA ONCOLOGY | ziftomenib | Oncology |
KYMAB | alomfilimab | Oncology |
KYMAB | amlitelimab | Oncology |
KYOWA KIRIN | POTELIGEO | Oncology |
LEAP THERAPEUTICS | surexatamab | Oncology |
LIGAND PHARMACEUTICALS | ONTAK | Oncology |
LIGAND PHARMACEUTICALS | TARGRETIN * | Oncology |
LOXO ONCOLOGY | larotrectinib | Oncology |
LOXO ONCOLOGY | RETEVMO | Oncology |
LOXO ONCOLOGY | selitrectinib | Oncology |
LOXO ONCOLOGY | selpercatinib | Oncology |
LOXO ONCOLOGY | VITRAKVI * | Oncology |
LSK BIOPHARMA | rivoceranib | Oncology |
LUNDBECK | ingenol disoxate | Oncology |
LUNDBECK | TREANDA * | Oncology |
LUNDBECK | TRISENOX * | Oncology |
LYCERA | cintirorgon | Oncology |
LYTIX BIOPHARMA | ruxotemitide | Oncology |
MABXIENCE RESEARCH SL | ALYMSYS | Oncology |
MACROGENICS | lorigerlimab | Oncology |
MACROGENICS | lorigerlimab | Oncology |
MACROGENICS | MARGENZA | Oncology |
MACROGENICS | vobramitamab | Oncology |
MACROGENICS | vobramitamab duocarmazine | Oncology |
MARKER THERAPEUTICS | zedenoleucel | Oncology |
MARKER THERAPEUTICS | zedenoleucel | Oncology |
MAST THERAPEUTICS | folitixorin | Oncology |
MAST THERAPEUTICS | folitixorin calcium | Oncology |
MEDICENNA THERAPEUTICS | bizaxofusp | Oncology |
MEDIMMUNE | blinatumomab | Oncology |
MEDIMMUNE | efgivanermin alfa | Oncology |
MEDIMMUNE | etaracizumab | Oncology |
MEDIMMUNE | moxetumomab pasudotox | Oncology |
MEDIVIR | fostroxacitabine bralpamide | Oncology |
MEI PHARMA | zandelisib | Oncology |
MERCK & CO. | baloramotide | Oncology |
MERCK & CO. | belzutifan | Oncology |
MERCK & CO. | cadalimogene ixalentivec | Oncology |
MERCK & CO. | derazantinib | Oncology |
MERCK & CO. | derazantinib hydrochloride | Oncology |
MERCK & CO. | KEYTRUDA | Oncology |
MERCK & CO. | lapretolimod | Oncology |
MERCK & CO. | miransertib | Oncology |
MERCK & CO. | nemtabrutinib | Oncology |
MERCK & CO. | pembrolizumab | Oncology |
MERCK & CO. | SYLATRON | Oncology |
MERCK & CO. | TEMODAR * | Oncology |
MERCK & CO. | vevorisertib | Oncology |
MERCK & CO. | WELIREG | Oncology |
MERCK & CO. | ZOLINZA | Oncology |
MEREO BIOPHARM | brontictuzumab | Oncology |
MEREO BIOPHARM | demcizumab | Oncology |
MEREO BIOPHARM | efaprinermin alfa | Oncology |
MEREO BIOPHARM | etigilimab | Oncology |
MEREO BIOPHARM | ipafricept | Oncology |
MEREO BIOPHARM | navicixizumab | Oncology |
MEREO BIOPHARM | rosmantuzumab | Oncology |
MEREO BIOPHARM | tarextumab | Oncology |
MEREO BIOPHARM | vantictumab | Oncology |
MERUS | zenocutuzumab | Oncology |
MILTENYI | zamtocabtagene autoleucel | Oncology |
MIRATI THERAPEUTICS | adagrasib | Oncology |
MIRATI THERAPEUTICS | glesatinib | Oncology |
MIRATI THERAPEUTICS | KRAZATI * | Oncology |
MIRATI THERAPEUTICS | mocetinostat | Oncology |
MIRATI THERAPEUTICS | mocetinostat dihydrobromide | Oncology |
MIRATI THERAPEUTICS | sitravatinib | Oncology |
MODERNA | acavameran | Oncology |
MOLECULAR TEMPLATES | cemavafusp | Oncology |
MOLECULAR TEMPLATES | molecular templates | Oncology |
MOLOGEN | lefitolimod | Oncology |
MONOPAR | camsirubicin | Oncology |
MORPHOSYS | felzartamab | Oncology |
MORPHOSYS | tafasitamab | Oncology |
MUNDIPHARMA | DIFOLTA | Oncology |
MUNDIPHARMA | tinostamustine | Oncology |
MYOVANT SCIENCES | ORGOVYX | Oncology |
MYRIAD | verubulin | Oncology |
NANOCARRIER | demplatin pegraglumer | Oncology |
NEKTAR | avipendekin pegol | Oncology |
NEKTAR | bempegaldesleukin | Oncology |
NEKTAR | etirinotecan pegol | Oncology |
NEKTAR | etirinotecan pegol tetrahydrochloride | Oncology |
NEKTAR | etirinotecan pegol tetratriflutate | Oncology |
NEOGENIX ONCOLOGY | ensituximab | Oncology |
NEWRON | XADAGO * | Oncology |
NIMBUS | zasocitinib | Oncology |
NIPPON KAYAKU | firtecan peglumer | Oncology |
NORTHWEST | murcidencel | Oncology |
NOVARTIS | AFINITOR | Oncology |
NOVARTIS | AMDRAY * | Oncology |
NOVARTIS | batoprotafib | Oncology |
NOVARTIS | dovitinib | Oncology |
NOVARTIS | dovitinib lactate | Oncology |
NOVARTIS | FARYDAK * | Oncology |
NOVARTIS | JAKAVI | Oncology |
NOVARTIS | KYMRIAH | Oncology |
NOVARTIS | lucatumumab | Oncology |
NOVARTIS | ODOMZO | Oncology |
NOVARTIS | PIQRAY * | Oncology |
NOVARTIS | PLUVICTO | Oncology |
NOVARTIS | rapcabtagene autoleucel | Oncology |
NOVARTIS | RYDAPT | Oncology |
NOVARTIS | SCEMBLIX * | Oncology |
NOVARTIS | TABRECTA (タブレクタ) * | Oncology |
NOVARTIS | TASIGNA | Oncology |
NOVARTIS | tisagenlecleucel | Oncology |
NOVARTIS | VOTUBIA | Oncology |
NOVARTIS | ZOMETA * | Oncology |
NOVARTIS | ZYKADIA * | Oncology |
NOVARTIS EUROPHARM LIMITED | FINLEE | Oncology |
NOVARTIS PHARMACEUTICALS CANADA INC | TABRECTA | Oncology |
NUCANA | fosgemcitabine palabenamide | Oncology |
NUCANA | fosifloxuridine nafalbenamide | Oncology |
NUVALENT | zidesamtinib | Oncology |
NUVATION BIO | inixaciclib | Oncology |
OASMIA PHARMACEUTICALS | APEALEA | Oncology |
OCTREOPHARM | satoreotide trizoxetan | Oncology |
ONCOLYS | suratadenoturev | Oncology |
ONCONOVA THERAPEUTICS | narazaciclib | Oncology |
ONCOPEPTIDES | melphalan flufenamide | Oncology |
ONCOPEPTIDES AB | PEPAXTI | Oncology |
ONCOPEPTIDES AB | PEPAXTO | Oncology |
ONCOSEC | tavokinogene telseplasmid | Oncology |
ONCOTHERAPY SCIENCE | elpamotide | Oncology |
ONCOTHERAPY SCIENCE | latromotide | Oncology |
ONCOTHERAPY SCIENCE | pradimotide | Oncology |
ONCOTHERAPYSCIENCE | tabituximab | Oncology |
ONCOTHERAPYSCIENCE | tabituximab barzuxetan | Oncology |
ONO PHARMACEUTICAL | tamnorzatinib | Oncology |
ONO PHARMACEUTICALS | VELEXBRU (ベレキシブル) | Oncology |
ONXEO | etidaligide | Oncology |
OSCOTEC | denfivotinib | Oncology |
OSI PHARMACEUTICALS | linsitinib | Oncology |
OSI PHARMACEUTICALS | TARCEVA * | Oncology |
OTSUKA PHARMACEUTICAL | INAQOVI | Oncology |
OTSUKA PHARMACEUTICAL | INQOVI * | Oncology |
OXFORD | oberotatug | Oncology |
OXFORD | oberotatug ravtansine | Oncology |
OXIGENE | fosbretabulin | Oncology |
OXIGENE | fosbretabulin disodium | Oncology |
OXIGENE | fosbretabulin tromethamine | Oncology |
PASSAGE BIO | ompenaclid | Oncology |
PDS BIOTECHNOLOGY | pexipepimut-s | Oncology |
PENDOPHARM | DEMYLOCAN * | Oncology |
PENDOPHARM | ZEULIDE DEPOT * | Oncology |
PENTIXAPHARM | gallium (68ga) boclatixafortide | Oncology |
PENTIXAPHARM | yttrium (90y) anditixafortide | Oncology |
PFIZER | agatolimod | Oncology |
PFIZER | BESPONSA | Oncology |
PFIZER | BRAFTOVI * | Oncology |
PFIZER | DAURISMO | Oncology |
PFIZER | elranatamab | Oncology |
PFIZER | elranatamab | Oncology |
PFIZER | ELREXFIO | Oncology |
PFIZER | enzalutamide | Oncology |
PFIZER | gemtuzumab ozogamicin | Oncology |
PFIZER | IBRANCE | Oncology |
PFIZER | LORBRENA | Oncology |
PFIZER | LORBRENA (ローブレナ) * | Oncology |
PFIZER | LORVIQUA | Oncology |
PFIZER | MEKTOVI * | Oncology |
PFIZER | METARET | Oncology |
PFIZER | MYLOTARG | Oncology |
PFIZER | ponsegromab | Oncology |
PFIZER | RUXIENCE * | Oncology |
PFIZER | SYNTHOKINE | Oncology |
PFIZER | tagtociclib | Oncology |
PFIZER | talazoparib | Oncology |
PFIZER | TALZENNA | Oncology |
PFIZER | tinlorafenib | Oncology |
PFIZER | TRAZIMERA * | Oncology |
PFIZER | TRELSTAR | Oncology |
PFIZER | VIZIMPRO | Oncology |
PFIZER | XTANDI * | Oncology |
PFIZER | ZIRABEV * | Oncology |
PFIZER CANADA ULC | BENVYON | Oncology |
PHARMACYCLICS | abexinostat | Oncology |
PHARMACYCLICS | ibrutinib | Oncology |
PHARMACYCLICS | IMBRUVICA * | Oncology |
PHARMAMAR | ZEPZELCA * | Oncology |
PHARMAMAR | ZEPZELCA * | Oncology |
PHOSPLATIN THERAPEUTICS | imifoplatin | Oncology |
PIERIS PHARMACEUTICALS | cinrebafusp alfa | Oncology |
PIERRE FABRE | BRAFTOVI * | Oncology |
PIERRE FABRE | MEKTOVI * | Oncology |
PIQUR | bimiralisib | Oncology |
PLUS THERAPEUTICS | rhenium (186re) obisbemeda | Oncology |
PUMA BIOTECHNOLOGY | NERLYNX * | Oncology |
PYRAMID BIOSCIENCES | paltimatrectinib | Oncology |
QED THERAPEUTICS | TRUSELTIQ | Oncology |
QILU PHARMACEUTICAL | iruplinalkib | Oncology |
QLT USA | ELIGARD | Oncology |
QURIENT | adrixetinib | Oncology |
RADIUS HEALTH | elacestrant | Oncology |
RADIUS HEALTH | vosilasarm | Oncology |
RAFAEL PHARMACEUTICALS | devimistat | Oncology |
RAIN ONCOLOGY | milademetan tosylate | Oncology |
RAIN THERAPEUTICS | milademetan | Oncology |
RAPT THERAPEUTICS | tivumecirnon | Oncology |
REGENERON | davutamig | Oncology |
REGENERON | linvoseltamab | Oncology |
REGENERON | vonsetamig | Oncology |
REGENERON PHARMACEUTICALS | LIBTAYO * | Oncology |
REGENERON PHARMACEUTICALS | ubamatamab | Oncology |
REGENERON PHARMACEUTICALS | ZALTRAP | Oncology |
REZOLUTE | ersodetug | Oncology |
RGENIX | ompenaclid succinate | Oncology |
ROCHE | ALECENSARO * | Oncology |
ROCHE | eciskafusp alfa | Oncology |
ROCHE | forimtamig | Oncology |
ROCHE | GAZYVA * | Oncology |
ROCHE | GAZYVARO | Oncology |
ROCHE | imgatuzumab | Oncology |
ROCHE | KADCYLA (カドサイラ) | Oncology |
ROCHE | lomvastomig | Oncology |
ROCHE | LUNSUMIO | Oncology |
ROCHE | ROPOLIVY | Oncology |
ROCHE | TARCEVA * | Oncology |
ROCHE | tobemstomig | Oncology |
ROCHE | vopikitug | Oncology |
ROCHE | XELODA | Oncology |
SALARIUS | seclidemstat | Oncology |
SALARIUS | seclidemstat mesylate | Oncology |
SAMSUNG BIOEPIS | ONTRUZANT | Oncology |
SAMUMED | cirtuvivint | Oncology |
SANDOZ | RIXATHON | Oncology |
SANDOZ | RIXIMYO | Oncology |
SANDOZ GMBH | HERWENDA | Oncology |
SANOFI | amcenestrant | Oncology |
SANOFI | amcenestrant | Oncology |
SANOFI | ELIGARD | Oncology |
SANOFI | ELITEK | Oncology |
SANOFI | ELOXATIN | Oncology |
SANOFI | fedratinib | Oncology |
SANOFI | isatuximab | Oncology |
SANOFI | JEVTANA * | Oncology |
SANOFI | NILANDRON | Oncology |
SANOFI | pilaralisib | Oncology |
SANOFI | PLENAXIS * | Oncology |
SANOFI | SARCLISA (サークリサ) | Oncology |
SANOFI | seribantumab | Oncology |
SANOFI | TAXOTERE | Oncology |
SANOFI | voxtalisib | Oncology |
SANOFI | ZALTRAP | Oncology |
SANOFI GENZYME | gatralimab | Oncology |
SANOFI GENZYME | vociprotafib | Oncology |
SEAGEN | ADCETRIS (アドセトリス) * | Oncology |
SEAGEN | denintuzumab mafodotin | Oncology |
SEAGEN | enfortumab vedotin | Oncology |
SEAGEN | ladiratuzumab | Oncology |
SEAGEN | ladiratuzumab vedotin | Oncology |
SEAGEN | sonolisib | Oncology |
SEAGEN | TIVDAK | Oncology |
SEAGEN | tucatinib | Oncology |
SEAGEN | TUKYSA * | Oncology |
SEAGEN | vadastuximab | Oncology |
SEAGEN | vadastuximab talirine | Oncology |
SEAGEN | vorsetuzumab mafodotin | Oncology |
SEATTLE GENETICS | ADCETRIS | Oncology |
SEATTLE GENETICS | cifurtilimab | Oncology |
SERVIER | ASPARLAS | Oncology |
SERVIER | ONCASPAR | Oncology |
SHIONOGI PHARMA | alicdamotide | Oncology |
SHIONOGI PHARMA | asudemotide | Oncology |
SHIONOGI PHARMA | epertinib | Oncology |
SHIONOGI PHARMA | trempamotide | Oncology |
SIEMENS | flortanidazole (18f) | Oncology |
SIEMENS | flotegatide (18f) | Oncology |
SILLAJEN | pexastimogene devacirepvec | Oncology |
SIRNAOMICS | lixadesiran | Oncology |
SIRNAOMICS | pixofisiran | Oncology |
SOLASIA | DARVIAS | Oncology |
SPARC | vodobatinib | Oncology |
SPARC PHARMA | bexirestrant | Oncology |
SPECTRUM PHARMACEUTICALS | BELEODAQ | Oncology |
SPECTRUM PHARMACEUTICALS | belinostat | Oncology |
SPECTRUM PHARMACEUTICALS | BRAKIVA | Oncology |
SPECTRUM PHARMACEUTICALS | eramkafusp alfa | Oncology |
SPECTRUM PHARMACEUTICALS | FOLOTYN | Oncology |
SPECTRUM PHARMACEUTICALS | FUSILEV | Oncology |
SPECTRUM PHARMACEUTICALS | KHAPZORY | Oncology |
SPECTRUM PHARMACEUTICALS | KYRBAX | Oncology |
SPECTRUM PHARMACEUTICALS | MARQIBO | Oncology |
SPECTRUM PHARMACEUTICALS | ZEVALIN | Oncology |
ST PHARM | basroparib | Oncology |
STADA | OYAVAS * | Oncology |
STEMLINE THERAPEUTICS | ELZONRIS * | Oncology |
STEMLINE THERAPEUTICS | felezonexor | Oncology |
SUN PHARMA | INFUGEM * | Oncology |
SUN PHARMA | INFUSMART | Oncology |
SUN PHARMA | ODOMZO * | Oncology |
SUN PHARMA | TACLANTIS | Oncology |
SUNESIS PHARMACEUTICALS | QUINPREZO | Oncology |
SUNESIS PHARMACEUTICALS | vecabrutinib | Oncology |
SUNESIS PHARMACEUTICALS | vosaroxin | Oncology |
SURFACE ONCOLOGY | casdozokitug | Oncology |
SURFACE ONCOLOGY | perenostobart | Oncology |
SURFACE ONCOLOGY | urabrelimab | Oncology |
SYNDAX | axatilimab | Oncology |
SYNDEVRX | evexomostat | Oncology |
SYNTA PHARMACEUTICALS | elesclomol | Oncology |
SYNTA PHARMACEUTICALS | rosabulin | Oncology |
SYROS | mevociclib | Oncology |
SYSTIMMUNE | danvilostomig | Oncology |
SYSTIMMUNE | nebratamig | Oncology |
TAIHO PHARMA | AROKARIS | Oncology |
TAIHO PHARMA | LONSURF | Oncology |
TAIHO PHARMA | TEYSUNO * | Oncology |
TAIRX | foslinanib | Oncology |
TAKARA BIO | canerpaturev | Oncology |
TAKARA BIO | mipetresgene autoleucel | Oncology |
TAKARA BIO | tebrocabtagene autoleucel | Oncology |
TAKEDA | alisertib | Oncology |
TAKEDA | dazostinag | Oncology |
TAKEDA | EXKIVITY | Oncology |
TAKEDA | imalumab | Oncology |
TAKEDA | indusatumab | Oncology |
TAKEDA | indusatumab vedotin | Oncology |
TAKEDA | ixazomib | Oncology |
TAKEDA | mivavotinib | Oncology |
TAKEDA | mobocertinib | Oncology |
TAKEDA | NINLARO (Нинларо) | Oncology |
TAKEDA | orteronel | Oncology |
TAKEDA | raxorulimogene belzovacirepvec | Oncology |
TAKEDA | sapanisertib | Oncology |
TAKEDA | serabelisib | Oncology |
TAKEDA | siltocabnagene loxiveleucel | Oncology |
TAKEDA | simurosertib | Oncology |
TAKEDA | VELCADE | Oncology |
TARVEDA | locnartecan | Oncology |
TARVEDA | nendratereotide uzatansine | Oncology |
TARVEDA | nendratereotide | Oncology |
TELIX PHARMACEUTICALS | rosopatamab | Oncology |
TELIX PHARMACEUTICALS | rosopatamab tetraxetan | Oncology |
TESARO | ZEJULA | Oncology |
TEVA PHARMACEUTICAL INDUSTRIES | BELRAPZO | Oncology |
TEVA PHARMACEUTICAL INDUSTRIES | BENDEKA * | Oncology |
TEVA PHARMACEUTICAL INDUSTRIES | TRUXIMA * | Oncology |
TEVA PHARMACEUTICALS INDUSTRIES | omacetaxine mepesuccinate | Oncology |
TEVA PHARMACEUTICALS INDUSTRIES | PAZENIR | Oncology |
TEVA PHARMACEUTICALS INDUSTRIES | SYNRIBO * | Oncology |
TEVA PHARMACEUTICALS INDUSTRIES | TREANDA * | Oncology |
THERATECHNOLOGIES | sudocetaxel | Oncology |
THERATECHNOLOGIES | sudocetaxel zendusortide | Oncology |
THERATECHNOLOGIES | sudocetaxel zendusortide | Oncology |
THERATECHNOLOGIES | zendusortide | Oncology |
THRESHOLD PHARMACEUTICALS | tarloxotinib bromide | Oncology |
TIBURIO | onzigolide | Oncology |
TRACON PHARMACEUTICALS | carotuximab | Oncology |
TRANSCENTA | betifisolimab | Oncology |
TRANSCENTA | osemitamab | Oncology |
TURNING POINT | zotizalkib | Oncology |
TURNING POINT THERAPEUTICS | elzovantinib | Oncology |
TURNING POINT THERAPEUTICS | enbezotinib | Oncology |
TYROGENEX | vorolanib | Oncology |
UCB | ginisortamab | Oncology |
UNITED THERAPEUTICS | UNITUXIN | Oncology |
UROGEN PHARMA | JELMYTO * | Oncology |
VELOSBIO | zilovertamab | Oncology |
VELOSBIO | zilovertamab vedotin | Oncology |
VERTEX PHARMACEUTICALS | berzosertib | Oncology |
VINCERX PHARMA | enitociclib | Oncology |
VION | laromustine | Oncology |
VOR BIOPHARMA | tremtelectogene empogeditemcel | Oncology |
WELLSTAT THERAPEUTICS | VISTOGARD | Oncology |
X4 PHARMACEUTICALS | mavorixafor | Oncology |
XCOVERY | ensartinib | Oncology |
XSPRAY PHARMA | DASYNOC | Oncology |
Y-BIOLOGICS | acrixolimab | Oncology |
Y-MABS THERAPEUTICS | DANYELZA * | Oncology |
YM BIOSCIENCES | lexibulin | Oncology |
ZODIAC PRODUTOS FARMACÊUTICOS | PADCEV | Oncology |
ZYMEWORKS | zanidatamab | Oncology |
ZYMEWORKS | zanidatamab zovodotin | Oncology |
ZYMOGENETICS | CERVATEC | Oncology |